Benzinga··Vandana SinghBofA Initiates Buy on Ligand Pharma, Sees $244 Upside in Royalty Model
Bank of America initiates Buy coverage on Ligand Pharmaceuticals with $244 price target, citing differentiated royalty model and strong Q4 results beating earnings expectations.
LGNDportfolio diversificationearnings beat